LABT

$0.47+146.08%visit website

Lakewood-Amedex Biotherapeutics Inc.

Market Cap

$5M

Finnhub, as of 2026-09-20

Sector

Health Care

Industry

Biotechnology

Beta (raw)

—

Insufficient price history

P/E (TTM)

—

Price / TTM diluted EPS

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

—

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Mar 2025 Mar 31, 2025	Jun 2025 Jun 30, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026
Cost of revenue			507
Research & development	170	147	182	503
Total operating expenses	543	637	887	3,790
Operating income	(543)	(637)	(887)	(3,790)
Interest expense	1.3	23.9	38.2	10.6
Net income	(540)	(656)	(923)	(3,772)
EPS (basic) ($)	(0.15)	(1.66)	(0.20)	(2.75)
EPS (diluted) ($)	(0.15)	(1.66)	(0.20)	(2.75)
Weighted avg. shares (basic)	6,943	694	6,995	1,420
Weighted avg. shares (diluted)	6,943	694	6,995	1,420

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 14, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source